INHIBITION OF EOSINOPHIL CYCLIC-NUCLEOTIDE PDE ACTIVITY AND OPSONISED ZYMOSAN-STIMULATED RESPIRATORY BURST BY TYPE-IV-SELECTIVE PDE INHIBITORS

被引:134
作者
DENT, G [1 ]
GIEMBYCZ, MA [1 ]
RABE, KF [1 ]
BARNES, PJ [1 ]
机构
[1] NATL HEART & LUNG INST, DEPT THORAC MED, DOVEHOUSE ST, LONDON SW3 6LY, ENGLAND
关键词
EOSINOPHILS; PHOSPHODIESTERASES; PHOSPHODIESTERASE INHIBITORS; HYDROGEN PEROXIDE; RESPIRATORY BURST;
D O I
10.1111/j.1476-5381.1991.tb09790.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The cyclic nucleotide phosphodiesterase (PDE) of guinea-pig eosinophils was partially characterized and the effects of selective inhibitors of PDE isoenzymes upon opsonized zymosan (OZ)-stimulated respiratory burst were studied. 2 PDE activity in eosinophil lysates appeared to be membrane-associated, displayed substrate specificity for adenosine 3':5' cyclic monophosphate (cyclic AMP) versus guanosine 3':5' cyclic monophosphate (cyclic GMP) and was insensitive to cyclic GMP or Ca2+ and calmodulin. 3 The non-selective PDE inhibitor, 3-isobutyl-1-methylxanthine caused a concentration-dependent inhibition of both OZ-stimulated hydrogen peroxide (H2O2) generation and cyclic AMP hydrolysis. The type IV-selective PDE inhibitors, rolipram and denbufylline, also inhibited H2O2 generation and cyclic AMP hydrolysis in a concentration-dependent manner whilst SK&F 94120 and Org 9935 (type III-selective) and zaprinast (type Ia or V-selective) were ineffective. 4 Dibutyryl cyclic AMP, a cell-permeable, non-hydrolysable analogue of cyclic AMP, caused a concentration-dependent inhibition of H2O2 generation stimulated by OZ. Dibutyryl cyclic GMP was ineffective. 5 It is concluded that eosinophil respiratory burst activity induced by OZ can be regulated by intracellular cyclic AMP and that the levels of cyclic AMP are controlled exclusively by a rolipram- and denbufylline-sensitive PDE isoenzyme that resembles a type IV species.
引用
收藏
页码:1339 / 1346
页数:8
相关论文
共 50 条
[1]  
BEAVO JA, 1988, ADV SEC MESS PHOSPH, V22, P1
[2]   PRIMARY SEQUENCE OF CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE ISOZYMES AND THE DESIGN OF SELECTIVE INHIBITORS [J].
BEAVO, JA ;
REIFSNYDER, DH .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1990, 11 (04) :150-155
[3]  
BONTA IL, 1984, ADV CYCLIC NUCL PROT, V17, P615
[4]  
BROTHERS VM, 1982, J BIOL CHEM, V257, P9349
[5]   ISOPROTERENOL INHIBITION OF ISOLATED HUMAN NEUTROPHIL FUNCTION [J].
BUSSE, WW ;
SOSMAN, JM .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1984, 73 (03) :404-410
[6]   SELECTIVITY OF ACTION CAN BE ACHIEVED WITH COMPOUNDS ACTING AT 2ND MESSENGER TARGETS [J].
CORDA, D ;
LUINI, A ;
GARATTINI, S .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1990, 11 (12) :471-473
[7]  
DEGERMAN E, 1987, J BIOL CHEM, V262, P5797
[8]  
DENT G, 1990, BRIT J PHARMACOL, V99, pP163
[9]   INTERACTIONS OF FORMYLMETHIONYL-LEUCYL-PHENYLALANINE, ADENOSINE, AND PHOSPHODIESTERASE INHIBITORS IN HUMAN-MONOCYTES - EFFECTS ON SUPEROXIDE RELEASE, INOSITOL PHOSPHATES AND CAMP [J].
ELLIOTT, KRF ;
LEONARD, EJ .
FEBS LETTERS, 1989, 254 (1-2) :94-98
[10]  
Fuller R W, 1988, Pulm Pharmacol, V1, P101, DOI 10.1016/S0952-0600(88)80006-1